Hangethe Consulting AB

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hangethe Consulting AB's trades of NextCell Pharma AB's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
B Purchase
51,648
436.56
SEK3,600,573 		51,648 436.56 SEK3,600,573
2024-06-18 2024-06-14
B Purchase
59,669
424.80
SEK1,776,621 		59,669 424.80 SEK1,776,621
2024-06-12 2024-06-11
B Purchase
52,818
418.40
SEK3,956,079 		52,818 418.40 SEK3,956,079
2024-06-11 2024-06-11
B Purchase
715,000
0.03
SEK19,794 		715,000 0.03 SEK19,794
2023-08-24 2023-08-24
B Purchase
2,500
3.95
SEK9,875 		2,500 3.95 SEK9,875
2023-08-24 2023-08-24
B Purchase
5,000
3.85
SEK19,250 		5,000 3.85 SEK19,250
2023-08-24 2023-08-24
B Purchase
7,900
3.90
SEK30,810 		7,900 3.90 SEK30,810